Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas

Volumn 49, Issue 12, 2016, Pages e5646-

  Andrade, E L ^a   Bento, A F ^a   Cavalli, J ^a   Oliveira, S K ^a   Schwanke, R C ^a   Siqueira, J M ^a   Freitas, C S ^a   Marcon, R ^a   Calixto, J B ^a  

^a Centro de Inova ão e Ensaios Pré Clínicos CIEnP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

ANIMAL; CHEMISTRY; CLINICAL PHARMACOLOGY; HUMAN; LABORATORY; MEDICAL RESEARCH; MUTAGEN TESTING; PHASE 1 CLINICAL TRIAL (TOPIC); PRECLINICAL STUDY; STANDARDS;

ANIMALS; BIOMEDICAL RESEARCH; CLINICAL TRIALS, PHASE I AS TOPIC; DRUG EVALUATION, PRECLINICAL; DRUGS, INVESTIGATIONAL; HUMANS; LABORATORIES; MUTAGENICITY TESTS; PHARMACOLOGY, CLINICAL;

EID: 85028073014     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20165646     Document Type: Review

References (0)